Aging cells are finally getting a classification system

Senescent cells (cells that have stopped dividing but do not die off) have long been linked to chronic inflammation and aging. But the variation between those cells was poorly understood. Researchers now propose distinct types, which they call ‘senotypes.’

In a Perspective article in Nature Aging, the researchers propose a framework that classifies senescent cells along three axes: how they arose, what molecular features they carry, and what they do in surrounding tissue. A senescent cell in the skin following UV damage behaves differently from one in a tumor, or in tissue recovering from a wound.

Some senescent cells serve a useful purpose

That distinction is not trivial. Some senotypes appear to play a protective or repair-promoting role, while others drive harmful chronic inflammation. Treating senescent cells as a uniform group risks eliminating beneficial variants alongside damaging ones.

The senotype framework provides a vocabulary to describe and compare that diversity across studies and tissues. It addresses a core problem in the field: findings are hard to compare because researchers use different definitions of what a senescent cell actually is.

Implications for treatment

This matters for longevity science. Much attention has focused on compounds that clear senescent cells from tissues. But if some senotypes are functionally important, selectivity becomes essential. The new framework offers a foundation for developing that selectivity: targeted intervention requires knowing which type of cell you are dealing with.

The authors emphasize that the Perspective is a conceptual proposal, not a definitive classification. It invites the research community to collect data in a standardized way, enabling comparisons across organs, species, and life stages.

Read the original article